.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advanced Endometrial Cancer

EP. 1: Overview of Endometrial Cancer

January 4th 2021

EP. 2: Risk Classification of Endometrial Cancer

January 4th 2021

EP. 3: Role of Biomarker Testing in Endometrial Cancer

January 4th 2021

EP. 4: GOG 0209 Study in Advanced Endometrial Cancer

January 4th 2021

EP. 5: GOG-249 Study in Early-Stage Endometrial Cancer

January 4th 2021

EP. 6: GOG-258 and PORTEC-3 Studies in Endometrial Cancer

January 4th 2021

EP. 7: Immune Checkpoint Inhibitors in Advanced Endometrial Cancer

January 4th 2021

EP. 8: Emerging ICI Therapy for Advanced Endometrial Cancer

January 4th 2021

EP. 9: Combination Therapy for Recurrent Endometrial Cancer

January 4th 2021

EP. 10: Recurrent Endometrial Cancer: Safety of Combination Therapy

January 4th 2021

EP. 11: Sequencing for Advanced Endometrial Cancer

January 4th 2021

EP. 12: Emerging Agents: Treatment of Endometrial Cancer

January 4th 2021

EP. 13: Endometrial Cancer: Chemo-Free Regimens on the Horizon

January 4th 2021

EP. 14: Novel Targets for Advanced Endometrial Cancer

January 4th 2021

EP. 15: Future of Advanced Endometrial Cancer

January 4th 2021